The SLC22A5 gene (also known as OCTN2) codes for the organic cation transporter novel 2 and is associated with the development of primary carnitine deficiency and cardiomyopathy (62, 63). This evidence concerns the gene SLC22A5 and systemic primary carnitine deficiency disease.